Literature DB >> 31656817

Is twice better than once?-challenges of troponin measurements for risk prediction in the general population.

Henning Jansen1,2, Dietrich Rothenbacher3, Wolfgang Koenig1,2,3.   

Abstract

Year:  2019        PMID： 31656817      PMCID： PMC6789312          DOI： 10.21037/atm.2019.08.03

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  11 in total

1.  Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.

Authors:  John W McEvoy; Yuan Chen; Chiadi E Ndumele; Scott D Solomon; Vijay Nambi; Christie M Ballantyne; Roger S Blumenthal; Josef Coresh; Elizabeth Selvin
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

2.  Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study.

Authors:  Atsushi Hozawa; Aaron R Folsom; A Richey Sharrett; Lloyd E Chambless
Journal:  Arch Intern Med       Date:  2007-03-26

3.  Fourth Universal Definition of Myocardial Infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

4.  Association of Repeatedly Measured High-Sensitivity-Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study.

Authors:  Maria F Hughes; Francisco Ojeda; Olli Saarela; Torben Jørgensen; Tanja Zeller; Tarja Palosaari; Mark G O'Doherty; Anders Borglykke; Kari Kuulasmaa; Stefan Blankenberg; Frank Kee
Journal:  Clin Chem       Date:  2016-11-15       Impact factor: 8.327

5.  Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.

Authors:  Torbjørn Omland; Marc A Pfeffer; Scott D Solomon; James A de Lemos; Helge Røsjø; Jūratė Šaltytė Benth; Aldo Maggioni; Michael J Domanski; Jean L Rouleau; Marc S Sabatine; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2013-02-13       Impact factor: 24.094

6.  Biomarker-based risk prediction in the community.

Authors:  Omar F AbouEzzeddine; Paul M McKie; Christopher G Scott; Richard J Rodeheffer; Horng H Chen; G Michael Felker; Allan S Jaffe; John C Burnett; Margaret M Redfield
Journal:  Eur J Heart Fail       Date:  2016-11       Impact factor: 15.534

7.  Temporal Changes in Cardiac Troponin I Are Associated with Risk of Cardiovascular Events in the General Population: The Nord-Trøndelag Health Study.

Authors:  Magnus N Lyngbakken; Helge Røsjø; Oddgeir L Holmen; Håvard Dalen; Kristian Hveem; Torbjørn Omland
Journal:  Clin Chem       Date:  2019-04-17       Impact factor: 8.327

8.  High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.

Authors:  Ian Ford; Anoop S V Shah; Ruiqi Zhang; David A McAllister; Fiona E Strachan; Muriel Caslake; David E Newby; Chris J Packard; Nicholas L Mills
Journal:  J Am Coll Cardiol       Date:  2016-12-27       Impact factor: 24.094

Review 9.  Novel biomarkers for cardiovascular risk prediction.

Authors:  Juan Wang; Guo-Juan Tan; Li-Na Han; Yong-Yi Bai; Miao He; Hong-Bin Liu
Journal:  J Geriatr Cardiol       Date:  2017-02       Impact factor: 3.327

10.  Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study.

Authors:  Henning Jansen; Andrea Jaensch; Ben Schöttker; Dhayana Dallmeier; Roman Schmucker; Hermann Brenner; Wolfgang Koenig; Dietrich Rothenbacher
Journal:  J Am Heart Assoc       Date:  2019-06-13       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.